METAVIA INC. Cash and Restricted Cash
METAVIA INC. (MTVA) had Cash and Restricted Cash of $12.63 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.63M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.73M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.28M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.28M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $12.63M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $13.73M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $10.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $14.28M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $17.59M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $11.19M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $16.02M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $21.67M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $27.93M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $15.99M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $22.43M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $25.84M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $28.69M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $30.81M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $33.36M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $6.36M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $8.85M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $11.56M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $16.39M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $6.98M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $9.51M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $13.04M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $10.09M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $12.35M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $14.30M 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $9.81M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $13.92M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $21.13M 10-Q · filed 2020-11-13 | $1.87M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $24.59M 10-Q · filed 2020-08-11 | $3.66M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.62M 10-Q · filed 2020-05-20 | $5.53M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.85M 10-K · filed 2021-04-15 | $18.95M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $23.81M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $28.04M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $34.46M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $50.00K 10-K · filed 2020-03-30 | $18.47M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |